Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
42.85
-0.96 (-2.19%)
At close: Oct 14, 2025, 4:00 PM EDT
42.85
0.00 (0.00%)
After-hours: Oct 14, 2025, 4:43 PM EDT
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $5.55 billion as of October 14, 2025. Its market cap has decreased by -59.72% in one year.
Market Cap
5.55B
Enterprise Value
4.08B
1-Year Change
-59.72%
Ranking
Category
Stock Price
$42.85
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $5.55B, an increase of 302.37%. That is a compound annual growth rate of 29.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2025 | 5.69B | -44.25% |
| Dec 31, 2024 | 10.20B | 70.74% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | 1.35B | -1.90% |
| Jun 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |